WHAT
MAKES US
UNIQUE

Aaron Ciechanover, MD, DSc

“T3 with its team of experts, has accompanied us in our efforts to commercialize our ubiquitin system-related discoveries. From connecting us to the best patent attorneys, all the way to negotiating multi-partner contracts, and now helping us in preparing for Phase 1 clinical trials. All along we’ve felt we are in the best hands possible.”

Aaron Ciechanover, MD, DSc

Laureate, the 2004 Nobel Prize in Chemistry
Distinguished University Professor
Faculty of Medicine, Technion-Israel Institute of Technology
Founder, TRIPOD Therapeutics Ltd.

Tomer Fuchs

“The T3 team has made a huge difference throughout the company’s life from the inception of Sealantis – founded by Prof. Havazelet Binco-Peled, to its acquisition by AMS.”

Tomer Fuchs

Project Director
Advanced Medical Solutions Israel (Sealantis) Ltd.

Prof. Avi Schroeder

“T3’s professional team bridges the science and business needs in each project, constructing successful new companies and long-lasting industrial collaborations.”

Prof. Avi Schroeder

Faculty of Chemical Engineering, Technion-Israel Institute of Technology
Founder, Barcode Diagnostics Ltd., ViAqua Therapeutics Ltd., Inplant Technologies Ltd., RNAWAY Ltd., Mana-BIO Ltd.

Doron D. Patt

“The T3 team provided invaluable access to the Technion’s faculty when scientific authority and guidance were needed for our R&D projects.”

Doron D. Patt

CEO & Co-Chairman, SLP Ltd.
Founded by Prof. Peretz Lavie

our new tracks